References
- Acharya, S., Yasmin, E., & Balen, A.H. (2009). The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies–a report of 20 cases. Human Fertility, 12, 198–203. doi: https://doi.org/10.3109/14647270903377178.
- Alcázar, J.L., Mercé, L.T., Manero, M.G., Bau, S., & López-García, G. (2005). Endometrial volume and vascularity measurements by transvaginal 3-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: An interobserver reproducibility study. Journal of Ultrasound in Medicine, 24, 1091–1098. doi: https://doi.org/10.7863/jum.2005.24.8.1091.
- Berman, B., & Duncan, M.R. (1989). Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. Journal of Investigative Dermatology, 92, 605–610. doi: https://doi.org/10.1111/1523-1747.ep12712140.
- Bordes, A., Bory, A.M., Benchaïb, M., Rudigoz, R.C., & Salle, B. (2002). Reproducibility of transvaginal three-dimensional endometrial volume measurements with virtual organ computer-aided analysis (VOCAL) during ovarian stimulation. Ultrasound in Obstetrics and Gynecology, 19, 76–80. doi: https://doi.org/10.1046/j.0960-7692.2001.00550.x.
- Chiao, T.B., & Lee, A.J. (2005). Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Annals of Pharmacotherapy, 39, 516–522. doi: https://doi.org/10.1345/aph.1E186.
- Claycombe, K.J., & Meydani, S.N. (2001). Vitamin E and genome stability. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 475, 37–44. doi: https://doi.org/10.1016/S0027-5107(01)00077-X.
- Coelho Neto, M.A., Martins, W.P., Lima, M.L.S., Barbosa, M.A.P., Nastri, C.O., Ferriani, R.A., & Navarro, P.A. (2015). Ovarian response is a better predictor of clinical pregnancy rate following embryo transfer than is thin endometrium or presence of an endometrioma. Ultrasound in Obstetrics & Gynecology, 46, 501–505. doi: https://doi.org/10.1002/uog.14884.
- Delabaere, A., Huchon, C., Lavoue, V., Lejeune, V., Iraola, E., Nedellec, S., … Deffieux, X. (2014). Standardisation de la terminologie des pertes de grossesse: consensus d’experts du Collège national des gynécologues et obstétriciens français (CNGOF) [Definition of pregnancy losses: Standardization of terminology from the French National College of Obstetricians and Gynecologists (CNGOF)]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 43, 756–763. doi: https://doi.org/10.1016/j.jgyn.2014.09.010.
- Delanian, S., Balla-Mekias, S., & Lefaix, J.L. (1999). Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. Journal of Clinical Oncology, 17, 3283–3290. doi: https://doi.org/10.1200/JCO.1999.17.10.3283.
- Delanian, S., Chatel, C., Porcher, R., Depondt, J., & Lefaix, J.-L. (2011). Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a Pentoxifylline-Tocopherol-Clodronate Combination (PENTOCLO): A Phase II Trial. International Journal of Radiation Oncology*Biology*Physics, 80, 832–839. doi: https://doi.org/10.1016/j.ijrobp.2010.03.029.
- Delanian, S., & Lefaix, J.-L. (2004). The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiotherapy and Oncology, 73, 119–131. doi: https://doi.org/10.1016/j.radonc.2004.08.021.
- Delanian, S., Porcher, R., Rudant, J., & Lefaix, J.-L. (2005). Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. Journal of Clinical Oncology, 23, 8570–8579. doi: https://doi.org/10.1200/JCO.2005.02.4729.
- Garcia-Velasco, J.A., Acevedo, B., Alvarez, C., Alvarez, M., Bellver, J., Fontes, J., … Rodriguez-Tabernero, L. (2016). Strategies to manage refractory endometrium: state of the art in 2016. Reproductive Biomedicine Online, 32, 474–489. doi: https://doi.org/10.1016/j.rbmo.2016.02.001.
- Gothard, L., Cornes, P., Brooker, S., Earl, J., Glees, J., Hall, E., … Yarnold, J. (2005). Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiotherapy and Oncology, 75, 334–341. doi: https://doi.org/10.1016/j.radonc.2005.02.002.
- Holden, E.C., Dodge, L.E., Sneeringer, R., Moragianni, V.A., Penzias, A.S., & Hacker, M.R. (2018). Thicker endometrial linings are associated with better IVF outcomes: a cohort of 6331 women. Human Fertility, 21, 288–293. doi: https://doi.org/10.1080/14647273.2017.1334130.
- Horvath, B., Marton, Z., Halmosi, R., Alexy, T., Szapary, L., Vekasi, J., … Toth, K. (2002). In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clinical Neuropharmacology, 25, 37–42. doi: https://doi.org/10.1097/00002826-200201000-00007.
- Jokubkiene, L., Sladkevicius, P., Rovas, L., & Valentin, L. (2006). Assessment of changes in endometrial and subendometrial volume and vascularity during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Ultrasound in Obstetrics and Gynecology, 27, 672–679. doi: https://doi.org/10.1002/uog.2742.
- Kamphuis, J., Smits, P., & Thien, T. (1994). Vascular effects of pentoxifylline in humans. Journal of Cardiovascular Pharmacology, 24, 648–654. Retrieved from: https://journals.lww.com/cardiovascularpharm/citation/1994/10000/vascular_effects_of_pentoxifylline_in_humans.16.aspx doi: https://doi.org/10.1097/00005344-199410000-00016.
- Kasius, A., Smit, J.G., Torrance, H.L., Eijkemans, M.J.C., Mol, B.W., Opmeer, B.C., & Broekmans, F.J.M. (2014). Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Human Reproduction Update, 20, 530–541. doi: https://doi.org/10.1093/humupd/dmu011.
- Lebovitz, O., & Orvieto, R. (2014). Treating patients with “thin” endometrium – an ongoing challenge. Gynecological Endocrinology, 30, 409–414. doi: https://doi.org/10.3109/09513590.2014.906571.
- Lédée, N., Prat-Ellenberg, L., Chevrier, L., Balet, R., Simon, C., Lenoble, C., … Petitbarat, M. (2017). Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study. Journal of Reproductive Immunology, 119, 23–30. doi: https://doi.org/10.1016/j.jri.2016.11.007.
- Lédée-Bataille, N., Olivennes, F., Lefaix, J.-L., Chaouat, G., Frydman, R., & Delanian, S. (2002). Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Human Reproduction, 17, 1249–1253. doi: https://doi.org/10.1093/humrep/17.5.1249.
- Lefaix, J.L., Delanian, S., Vozenin, M.C., Leplat, J.J., Tricaud, Y., & Martin, M. (1999). Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: An experimental study. International Journal of Radiation Oncology*Biology*Physics, 43, 839–847. doi: https://doi.org/10.1016/S0360-3016(98)00419-2.
- Letur-Könirsch, H., Cohen, H., Guis, F., & Delanian, S. (2001). Complete endometrial healing by reversion of radiation-induced abrasion after combined pentoxifylline and tocopherol treatment. Reproductive Technologies, 10, 330–331. Retrieved from: https://www.researchgate.net/publication/292562464_Complete_endometrial_healing_by_reversion_of_radiation-induced_abrasion_after_combined_pentoxifylline_and_tocopherol_treatment
- Letur-Könirsch, H., Guis, F., & Delanian, S. (2002). Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study. Fertility and Sterility, 77, 1219–1226. doi: https://doi.org/10.1016/S0015-0282(02)03120-5.
- Ma, N.-Z., Chen, L., Dai, W., Bu, Z.-Q., Hu, L.-L., & Sun, Y.-P. (2017). Influence of endometrial thickness on treatment outcomes following in vitro fertilization/intracytoplasmic sperm injection. Reproductive Biology and Endocrinology, 15, 5. doi: https://doi.org/10.1186/s12958-016-0222-5.
- Marques, L.J., Zheng, L., Poulakis, N., Guzman, J., & Costabel, U. (1999). Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. American Journal of Respiratory and Critical Care Medicine, 159, 508–511. doi: https://doi.org/10.1164/ajrccm.159.2.9804085.
- Raga, F., Bonilla-Musoles, F., Casañ, E.M., Klein, O., & Bonilla, F. (1999). Assessment of endometrial volume by three-dimensional ultrasound prior to embryo transfer: Clues to endometrial receptivity. Human Reproduction, 14, 2851–2854. doi: https://doi.org/10.1093/humrep/14.11.2851.
- Raine-Fenning, N.J., Campbell, B.K., Clewes, J.S., Kendall, N.R., & Johnson, I.R. (2004). Defining endometrial growth during the menstrual cycle with three-dimensional ultrasound. BJOG: An International Journal of Obstetrics & Gynaecology, 111, 944–949. doi: https://doi.org/10.1111/j.1471-0528.2004.00214.x.
- Simon, A., & Laufer, N. (2012). Assessment and treatment of repeated implantation failure (RIF). Journal of Assisted Reproduction and Genetics, 29, 1227–1239. doi: https://doi.org/10.1007/s10815-012-9861-4.
- Yaman, C., Ebner, T., Sommergruber, M., Pölz, W., & Tews, G. (2000). Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: A preliminary study. Fertility and Sterility, 74, 797–801. doi: https://doi.org/10.1016/S0015-0282(00)01493-X.
- Yaman, C., Jesacher, K., & Pölz, W. (2003). Accuracy of three-dimensional transvaginal ultrasound in uterus volume measurements; comparison with two-dimensional ultrasound. Ultrasound in Medicine & Biology, 29, 1681–1684.5629, (03)01070-6. doi: https://doi.org/10.1016/S0301.
- Yaman, C., & Mayer, R. (2012). Three-dimensional ultrasound as a predictor of pregnancy in patients undergoing ART. Journal of the Turkish German Gynecological Association, 13, 128–134. doi: https://doi.org/10.5152/jtgga.2012.15.
- Yaman, C., Sommergruber, M., Ebner, T., PöLz, W., Moser, M., & Tews, G. (1999). Reproducibility of transvaginal three-dimensional endometrial volume measurements during ovarian stimulation. Human Reproduction, 14, 2604–2608. doi: https://doi.org/10.1093/humrep/14.10.2604.
- Yuan, X., Saravelos, S.H., Wang, Q., Xu, Y., Li, T.-C., & Zhou, C. (2016). Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF–ICSI cycles. Reproductive Biomedicine Online, 33, 197–205. doi: https://doi.org/10.1016/j.rbmo.2016.05.002.
- Zhao, J., Zhang, Q., Wang, Y., & Li, Y. (2014). Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. Reproductive Biomedicine Online, 29, 291–298. doi: https://doi.org/10.1016/j.rbmo.2014.05.011.
- Zohav, E., Orvieto, R., Anteby, E.Y., Segal, O., Meltcer, S., & Tur-Kaspa, I. (2007). Low endometrial volume may predict early pregnancy loss in women undergoing in vitro fertilization. Journal of Assisted Reproduction and Genetics, 24, 259–261. doi: https://doi.org/10.1007/s10815-007-9121-1.
- Zollner, U., Zollner, K.-P., Specketer, M.-T., Blissing, S., Müller, T., Steck, T., & Dietl, J. (2003). Endometrial volume as assessed by three-dimensional ultrasound is a predictor of pregnancy outcome after in vitro fertilization and embryo transfer. Fertility and Sterility, 80, 1515–1517. doi: https://doi.org/10.1016/j.fertnstert.2003.08.004.